These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16513418)

  • 1. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats.
    Philipp S; Jürgensen JS; Fielitz J; Bernhardt WM; Weidemann A; Schiche A; Pilz B; Dietz R; Regitz-Zagrosek V; Eckardt KU; Willenbrock R
    Eur J Heart Fail; 2006 Jun; 8(4):347-54. PubMed ID: 16513418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
    Bao W; Qin P; Needle S; Erickson-Miller CL; Duffy KJ; Ariazi JL; Zhao S; Olzinski AR; Behm DJ; Pipes GC; Jucker BM; Hu E; Lepore JJ; Willette RN
    J Cardiovasc Pharmacol; 2010 Aug; 56(2):147-55. PubMed ID: 20714241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain.
    Jones NM; Lee EM; Brown TG; Jarrott B; Beart PM
    Neurosci Lett; 2006 Aug; 404(1-2):72-7. PubMed ID: 16828226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
    Nangaku M; Izuhara Y; Takizawa S; Yamashita T; Fujii-Kuriyama Y; Ohneda O; Yamamoto M; van Ypersele de Strihou C; Hirayama N; Miyata T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2548-54. PubMed ID: 17932321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype.
    Irwin R; LaPres JJ; Kinser S; McCabe LR
    J Cell Biochem; 2007 Feb; 100(3):762-72. PubMed ID: 17031858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF prolyl hydroxylase inhibitors for anemia.
    Muchnik E; Kaplan J
    Expert Opin Investig Drugs; 2011 May; 20(5):645-56. PubMed ID: 21406036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo.
    Witten L; Sager T; Thirstrup K; Johansen JL; Larsen DB; Montezinho LP; Mørk A
    J Neurosci Res; 2009 May; 87(7):1686-94. PubMed ID: 19156859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor.
    Barrett TD; Palomino HL; Brondstetter TI; Kanelakis KC; Wu X; Haug PV; Yan W; Young A; Hua H; Hart JC; Tran DT; Venkatesan H; Rosen MD; Peltier HM; Sepassi K; Rizzolio MC; Bembenek SD; Mirzadegan T; Rabinowitz MH; Shankley NP
    Mol Pharmacol; 2011 Jun; 79(6):910-20. PubMed ID: 21372172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity.
    Wirthner R; Balamurugan K; Stiehl DP; Barth S; Spielmann P; Oehme F; Flamme I; Katschinski DM; Wenger RH; Camenisch G
    Methods Enzymol; 2007; 435():43-60. PubMed ID: 17998048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
    Bernhardt WM; Câmpean V; Kany S; Jürgensen JS; Weidemann A; Warnecke C; Arend M; Klaus S; Günzler V; Amann K; Willam C; Wiesener MS; Eckardt KU
    J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction.
    Parisi Q; Biondi-Zoccai GG; Abbate A; Santini D; Vasaturo F; Scarpa S; Bussani R; Leone AM; Petrolini A; Silvestri F; Biasucci LM; Baldi A
    Int J Cardiol; 2005 Mar; 99(2):337-9. PubMed ID: 15749199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
    Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
    Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of the rat HIF-1 alpha prolyl-4-hydroxylase-1 gene.
    Cobb RR; McClary J; Manzana W; Finster S; Larsen B; Blasko E; Pearson J; Biancalana S; Kauser K; Bringmann P; Light DR; Schirm S
    Protein Expr Purif; 2005 Aug; 42(2):295-304. PubMed ID: 15925519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
    Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.
    Kido M; Du L; Sullivan CC; Li X; Deutsch R; Jamieson SW; Thistlethwaite PA
    J Am Coll Cardiol; 2005 Dec; 46(11):2116-24. PubMed ID: 16325051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
    Lee SH; Wolf PL; Escudero R; Deutsch R; Jamieson SW; Thistlethwaite PA
    N Engl J Med; 2000 Mar; 342(9):626-33. PubMed ID: 10699162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.
    Vogler M; Zieseniss A; Hesse AR; Levent E; Tiburcy M; Heinze E; Burzlaff N; Schley G; Eckardt KU; Willam C; Katschinski DM
    Pflugers Arch; 2015 Oct; 467(10):2141-9. PubMed ID: 25578858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.